Literature DB >> 12879760

Recombinant single-chain Fv antibodies that recognize the p25 protein of the Maedi-Visna virus.

V Celer1, D Blazek, I Navrátilová, P Skládal, B Blacklaws, R Bujdoso.   

Abstract

Single chain Fv (scFv) antibodies (generated by phage display technology, molecules representing new and efficient tools in the research and diagnostics of infectious diseases) against the capsid protein (p25) of Maedi-Visna virus were selected. Several clones of p25 specific scFv antibodies were identified; one of them was expressed as a soluble scFv molecule, purified by immobilized metal-affinity chromatography and further characterized by sequencing and determination of the kinetic equilibrium association constant. Sequence analysis showed that the rearranged VL and VH domains of the analyzed scFv clone used sequences from the VL3 family (germline DPL16/VL3.1) and VH1 family (germline VH20), respectively. The kinetic equilibrium association constant was determined as KA = 1.12 +/- 0.52 L/mumol.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12879760     DOI: 10.1007/bf02931380

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.099


  21 in total

1.  Nucleotide sequence of the visna lentivirus: relationship to the AIDS virus.

Authors:  P Sonigo; M Alizon; K Staskus; D Klatzmann; S Cole; O Danos; E Retzel; P Tiollais; A Haase; S Wain-Hobson
Journal:  Cell       Date:  1985-08       Impact factor: 41.582

2.  Kinetics of ligand binding to receptor immobilized in a polymer matrix, as detected with an evanescent wave biosensor. I. A computer simulation of the influence of mass transport.

Authors:  P Schuck
Journal:  Biophys J       Date:  1996-03       Impact factor: 4.033

3.  Tropism of sheep lentiviruses for monocytes: susceptibility to infection and virus gene expression increase during maturation of monocytes to macrophages.

Authors:  H E Gendelman; O Narayan; S Kennedy-Stoskopf; P G Kennedy; Z Ghotbi; J E Clements; J Stanley; G Pezeshkpour
Journal:  J Virol       Date:  1986-04       Impact factor: 5.103

Review 4.  Generating improved single-chain Fv molecules for tumor targeting.

Authors:  G P Adams; R Schier
Journal:  J Immunol Methods       Date:  1999-12-10       Impact factor: 2.303

5.  Phage-displayed and soluble mouse scFv fragments neutralize rabies virus.

Authors:  B H Muller; F Lafay; C Demangel; P Perrin; N Tordo; A Flamand; P Lafaye; J L Guesdon
Journal:  J Virol Methods       Date:  1997-09       Impact factor: 2.014

6.  Neutralizing human anti crotoxin scFv isolated from a nonimmunized phage library.

Authors:  D F Cardoso; F Nato; P England; M L Ferreira; T J Vaughan; I Mota; J C Mazie; V Choumet; P Lafaye
Journal:  Scand J Immunol       Date:  2000-04       Impact factor: 3.487

Review 7.  Visna-maedi in sheep.

Authors:  M Gudnadóttir
Journal:  Prog Med Virol       Date:  1974

Review 8.  Ras and p53 intracellular targeting with recombinant single-chain Fv (scFv) fragments: a novel approach for cancer therapy?

Authors:  O Cochet; N Gruel; W H Fridman; J L Teillaud
Journal:  Cancer Detect Prev       Date:  1999

9.  Development of a monoclonal antibody blocking-ELISA for detection of antibodies against Maedi-Visna virus.

Authors:  M Fevereiro; S Barros; T Fagulha
Journal:  J Virol Methods       Date:  1999-08       Impact factor: 2.014

10.  By-passing immunization. Human antibodies from V-gene libraries displayed on phage.

Authors:  J D Marks; H R Hoogenboom; T P Bonnert; J McCafferty; A D Griffiths; G Winter
Journal:  J Mol Biol       Date:  1991-12-05       Impact factor: 5.469

View more
  2 in total

Review 1.  The production and application of single-chain antibody fragments.

Authors:  D Blazek; V Celer
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

2.  Recombinant single chain Fv antibodies specific for glycoprotein D of equid herpesvirus 1.

Authors:  D Molinková; V Celer
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.099

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.